Last reviewed · How we verify
NCT05692687
A Post-market Clinical Study to Evaluate the Safety and Performance of the Carbon Fibre Reinforced Polyetheretherketone Metatarso-Phalangeal (MTP) Plate (CoLink® PCR MTP Plate) for the Treatment of Hallux Rigidus
trial in Hallux Rigidus in 18 participants. Completed in 12 August 2025.
12 August 2025
Quick facts
| Lead sponsor | Invibio Ltd |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 18 |
| Start date | 15 March 2023 |
| Primary completion | 12 August 2025 |
| Estimated completion | 12 August 2025 |
| Sites | 3 locations across United States |
Conditions studied
- Hallux Rigidus — all drugs for Hallux Rigidus →
Sponsor
Invibio Ltd
Who can join
18 and older, any sex, with Hallux Rigidus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The clinical study involves the routine treatment of skeletally mature patients who have been diagnosed with hallux rigidus (stiffness of the first metatarso-phalangeal joint in the foot due to arthritis and degeneration of cartilage). It follows standard practice surgery to treat this condition. This type of degenerative arthritis affects the joint of the big toe (hallux) which is attached to the foot. Taking part in this research will involve collecting data of the surgery to remove damaged cartilage and fix the two bones together with screws and a plate (called the CoLink® PCR MTP Plate).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05692687
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hallux Rigidus
Currently open trials in the same condition.
- NCT05555459 — Performance and Safety Evaluation of Inion CompressOn Screw in Foot and Ankle Surgeries. PMCF Investigation · NA · recruiting
- NCT05795127 — Risk for Reoperation After First MTP Joint Arthrodesis · active not recruiting
- NCT04590313 — Efficacy of First MTPJ Arthrodesis as a Treatment in Hallux Rigidus · NA · active not recruiting
- NCT04473196 — The Effect of Weight Bearing on Patient Outcomes Following 1st MTP Joint Fusion · NA · recruiting
Other Invibio Ltd trials
Trials by the same sponsor.
- NCT06585267 — Development of a New Patient Reported Outcome Measure (PROM) to Assess Patient's Emotional Wellbeing, and Perceptions of · active not recruiting
- NCT05597046 — Qualitative Interviews With Healthcare Professionals · completed
- NCT04416321 — A Clinical Study to Evaluate Safety and Performance of PEEK-OPTIMA™ HA Enhanced. · NA · completed
- NCT03928041 — A Clinical Study to Evaluate Safety and Performance of PEEK-OPTIMA™ HA Enhanced Interbody Cages in the Lumbar Spine · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05692687 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Invibio Ltd
- Last refreshed: 19 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05692687.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing